Related Experiment Video
Updated: Jan 24, 2026

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
Published on: November 22, 2024
Therapeutic perspective on vascular cognitive impairment
Kensuke Toyama1, Joshua M Spin2, Masaki Mogi1
1Department of Pharmacology, Ehime University Graduate School of Medicine, Ehime, Japan.
Insights
Vascular risk factors contribute to dementia, often linked to blood-brain barrier (BBB) disruptions. MicroRNAs regulate BBB tight junctions, offering potential biomarkers and therapeutic targets for vascular cognitive impairment.
Area of Science:
- Neuroscience
- Gerontology
- Vascular Biology
Background:
- Dementia is a major public health challenge for aging populations.
- Research has shifted from amyloid-β to vascular risk factors in dementia.
- Vascular cognitive impairment (VCI) is increasingly recognized as a significant component of dementia.
Purpose of the Study:
- To review the role of microRNAs in regulating blood-brain barrier (BBB) integrity.
- To explore the potential of microRNAs as biomarkers for BBB dysfunction in VCI.
- To envision future therapeutic strategies targeting microRNAs for dementia treatment.
Main Methods:
- Review of current scientific literature on microRNAs, VCI, and BBB.
- Analysis of imaging studies showing BBB disruptions in VCI patients.
- Examination of microRNA regulation of tight junctions in cerebral endothelial cells.
Main Results:
- Vascular risk factors are strongly associated with various forms of dementia.
- Blood-brain barrier disruptions are observed in the white matter of VCI patients.
- MicroRNAs play a crucial role in regulating the tight junctions essential for BBB function.
Conclusions:
- Targeting blood vessels and BBB integrity is a promising therapeutic avenue for dementia.
- MicroRNAs represent potential biomarkers for BBB dysfunction in VCI.
- Further research into microRNA mechanisms could lead to novel dementia treatments.
Abstract:
Dementia is one of the greatest public health concerns for the modern aging world. Over the last decade, most researchers developing new therapeutic strategies for dementia have focused on amyloid-β. In contrast, numerous recent studies have indicated that vascular risk factors are associated with various forms of dementia, and that in fact most forms of dementia can be considered an extension of vascular disease. Accordingly, it is sensible to pursue treatment approaches that focus on the blood vessels. Blood-brain barrier (BBB) disruptions in the white matter of patients with vascular cognitive impairment (VCI) have been observed using imaging analysis, and might be potential targets for novel VCI treatment. Tight junctions between cerebral endothelial cells play an important role in the function of the BBB, and recent studies have demonstrated the essential role of microRNAs in regulating tight junctions. Further elucidation of the mechanisms of tight junction-disruption in dementia are likely to lead to promising novel treatments. In this article, we summarize current knowledge regarding microRNAs and vascular cognitive impairment and the possibility of utilizing microRNAs as biomarkers for BBB dysfunction, and seek to envision future therapeutic strategies.
Related Concept Videos
Social Cognitive Perspective on Personality
Cognitive Dissonance
Psychodynamic Perspectives on Personality
Psychodynamic theorists argue that unconscious...
The Behavioral Perspective on Personality
Criticisms of the Evolutionary Perspective
Evolutionary psychology provides one explanation for these findings, suggesting...
Seedless Vascular Plants

